Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 17, 2022 / 02:00PM GMT
Release Date Price: $168.26 (-0.65%)
Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst

Great. Thank you, Brad. Thanks for getting us going here. Hey, everybody. Welcome this morning to the third day of the Oppenheimer Healthcare Conference. My name is Hartaj Singh. I'm one of the biotechnology analysts over here. And it's a real pleasure to have one of the most innovative companies on the planet, in my opinion, with us today, the CFO, David Meline; and Lavina Talukdar, I still can't say it. Sorry, I'm just spelling names, but I have both of you here. We'll get going with David doing a quick presentation and then go to our fireside chat.

So David, please take it away.

David W. Meline
Moderna, Inc. - CFO & Principal Accounting Officer

Yes. Thank you very much, and good morning, afternoon to all. So what I'll do is just cover briefly '21, '22 and events that have occurred more recently since our last quarterly call.

So in terms of 2021, we delivered during the calendar year, some $18.5 billion of total revenue. Obviously, primarily our COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot